Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,455 | 46,600 | 38,772 | 38,410 | 24,681 |
| Marketable Securities | 257,288 | 299,904 | 356,784 | 390,955 | 452,465 |
| Receivables | 8,733 | 7,492 | 738 | 1,018 | 741 |
| Inventories | 236 | N/A | N/A | N/A | N/A |
| TOTAL | $279,088 | $357,874 | $398,737 | $439,454 | $492,158 |
| Non-Current Assets | |||||
| PPE Net | 18,995 | 19,390 | 19,854 | 20,350 | 20,753 |
| Intangibles | 97,753 | 97,900 | 97,900 | 97,900 | 97,900 |
| Other Non-Current Assets | 428 | 461 | 454 | 430 | 530 |
| TOTAL | $117,176 | $117,751 | $118,208 | $118,680 | $119,183 |
| Total Assets | $396,264 | $475,625 | $516,945 | $558,134 | $611,341 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15,753 | 16,280 | 16,792 | 17,289 | 2,020 |
| Accounts payable and accrued liabilities | 41,945 | 52,877 | 41,545 | 28,225 | 25,544 |
| Accrued Expenses | 10,191 | 32,114 | 32,906 | 23,950 | 23,615 |
| TOTAL | $137,061 | $164,643 | $170,113 | $130,992 | $121,943 |
| Non-Current Liabilities | |||||
| Long Term Debt | 85,268 | 85,167 | 85,038 | 84,909 | 100,550 |
| Deferred Revenues | 69,172 | 63,372 | 78,870 | 61,528 | 70,764 |
| Other Non-Current Liabilities | 559 | 805 | 2,500 | 14,037 | 14,593 |
| TOTAL | $124,600 | $153,581 | $161,651 | $209,809 | $236,517 |
| Total Liabilities | $261,661 | $318,224 | $331,764 | $340,801 | $358,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,235 | 104,320 | 104,036 | 103,866 | 103,821 |
| Common Shares | 105 | 105 | 104 | 104 | 104 |
| Retained earnings | -1,287,245 | -1,250,363 | -1,217,944 | -1,181,929 | -1,143,817 |
| Other shareholders' equity | -168 | -563 | -290 | -32 | -71 |
| TOTAL | $134,603 | $157,401 | $185,181 | $217,333 | $252,881 |
| Total Liabilities And Equity | $396,264 | $475,625 | $516,945 | $558,134 | $611,341 |